Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Locations section including Queensland and South Australia; updated the page revision to v3.3.3.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no core study content or details appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the banner that warned about potential delays in NIH operations due to funding and directed users to cc.nih.gov for status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe new screenshot shows a reflowed layout and minor text/label tweaks; core study details such as arms, outcomes, and eligibility criteria appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0 (removes v3.1.0).SummaryDifference5%

- Check97 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.